Total number of protein in "GO:0019229" GO term: 20
| Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACE-202 | ACE | P12821 | Angiotensin-converting enzyme | chr17 | GO:0019229 | Not Cancer Driver | No | 152 | 0.116385911179173 | 87 | 5 | 0.0038284839203675 | 0 |
| ACE2-201 | ACE2 | Q9BYF1 | Angiotensin-converting enzyme 2 | chrX | GO:0019229 | Not Cancer Driver | No | 67 | 0.0832298136645962 | 68 | 4 | 0.0049689440993788 | 0 |
| ADRA1B-201 | ADRA1B | P35368 | Alpha-1B adrenergic receptor | chr5 | GO:0019229 | Not Cancer Driver | No | 40 | 0.0769230769230769 | 133 | 1 | 0.0019230769230769 | 0 |
| ADRA2A-201 | ADRA2A | P08913 | Alpha-2A adrenergic receptor | chr10 | GO:0019229 | Not Cancer Driver | No | 46 | 0.0989247311827957 | 162 | 9 | 0.0193548387096774 | 0 |
| ADRA2C-201 | ADRA2C | P18825 | Alpha-2C adrenergic receptor | chr4 | GO:0019229 | Not Cancer Driver | No | 35 | 0.0757575757575757 | 107 | 0 | 0.0 | 0 |
| AGT-201 | AGT | P01019 | Angiotensinogen | chr1 | GO:0019229 | Not Cancer Driver | No | 61 | 0.1281512605042016 | 33 | 3 | 0.0063025210084033 | 1 |
| AGTR1-201 | AGTR1 | P30556 | Type-1 angiotensin II receptor | chr3 | GO:0019229 | Not Cancer Driver | No | 70 | 0.1949860724233983 | 0 | 0 | 0.0 | 1 |
| ASIC2-202 | ASIC2 | Q16515 | Acid-sensing ion channel 2 | chr17 | GO:0019229 | Not Cancer Driver | No | 82 | 0.16015625 | 49 | 1 | 0.001953125 | 0 |
| ATP1A2-201 | ATP1A2 | P50993 | Sodium/potassium-transporting ATPase subunit alpha-2 | chr1 | GO:0019229 | Not Cancer Driver | No | 162 | 0.1588235294117647 | 162 | 21 | 0.0205882352941176 | 14 |
| BDKRB2-203 | BDKRB2 | P30411 | B2 bradykinin receptor | chr14 | GO:0019229 | Not Cancer Driver | No | 60 | 0.1534526854219949 | 0 | 0 | 0.0 | 0 |
| ECE1-203 | ECE1 | P42892 | Endothelin-converting enzyme 1 | chr1 | GO:0019229 | Not Cancer Driver | No | 95 | 0.1233766233766233 | 99 | 21 | 0.0272727272727272 | 1 |
| EDN1-201 | EDN1 | P05305 | Endothelin-1 | chr6 | GO:0019229 | Not Cancer Driver | No | 27 | 0.1273584905660377 | 98 | 16 | 0.0754716981132075 | 3 |
| EDN2-201 | EDN2 | P20800 | Endothelin-2 | chr1 | GO:0019229 | Not Cancer Driver | No | 19 | 0.1067415730337078 | 87 | 11 | 0.0617977528089887 | 0 |
| EDN3-202 | EDN3 | P14138 | Endothelin-3 | chr20 | GO:0019229 | Not Cancer Driver | No | 51 | 0.2142857142857142 | 140 | 36 | 0.1512605042016806 | 3 |
| ENST00000614557 | KCNMB2 | Q9Y691 | Calcium-activated potassium channel subunit beta-2 | chr3 | GO:0019229 | Not Cancer Driver | No | 49 | 0.2085106382978723 | 0 | 0 | 0.0 | 0 |
| HTR1A-201 | HTR1A | P08908 | 5-hydroxytryptamine receptor 1A | chr5 | GO:0019229 | Not Cancer Driver | No | 134 | 0.3175355450236967 | 100 | 36 | 0.0853080568720379 | 0 |
| KCNA5-201 | KCNA5 | P22460 | Potassium voltage-gated channel subfamily A member 5 | chr12 | GO:0019229 | Not Cancer Driver | No | 185 | 0.3017944535073409 | 221 | 51 | 0.0831973898858075 | 0 |
| KCNMB2-207 | KCNMB2 | Q9Y691 | Calcium-activated potassium channel subunit beta-2 | chr3 | GO:0019229 | Not Cancer Driver | No | 49 | 0.2085106382978723 | 0 | 0 | 0.0 | 0 |
| KCNMB4-201 | KCNMB4 | Q86W47 | Calcium-activated potassium channel subunit beta-4 | chr12 | GO:0019229 | Not Cancer Driver | No | 24 | 0.1142857142857142 | 0 | 0 | 0.0 | 0 |
| PER2-201 | PER2 | O15055 | Period circadian protein homolog 2 | chr2 | GO:0019229 | Not Cancer Driver | No | 118 | 0.0940239043824701 | 783 | 72 | 0.0573705179282868 | 1 |